Complement (C3, C4) and C-reactive protein responses to cardiopulmonary bypass and protamine administration. 1993

M Tulunay, and S Demiralp, and S Tastan, and H Akalin, and U Ozyurda, and T Corapcioglu, and E S Akarsu
Department of Anaesthesiology, Ibn-i Sina Hospital, University of Ankara, Turkey.

Complement activation has been deemed responsible for the damaging effects of cardiopulmonary bypass (CPB) in patients undergoing open heart surgery. We studied C3, C4 and C-reactive protein (CRP) in 22 patients undergoing CPB. In Group 1 (11 patients), protamine was given intravenously and in Group 2 (11 patients), via the aortic root after CPB. Significant decreases were observed in C3 and C4 during CPB in both groups indicating complement activation primarily by the classic pathway. Protamine did not lead to further activation of the complement system. In both groups, C3 levels gradually returned toward baseline within 24 hours but C4 levels were still lower than baseline 24 hours postoperatively. CPB and protamine administration did not cause any significant changes in CRP levels, but CRP increased abruptly 24 hours after operation. Although activation of complement system during CPB is expected to invoke an acute phase response, we conclude that this period is not long enough to induce an increased production of CRP in response to tissue injury or inflammation.

UI MeSH Term Description Entries
D007269 Injections, Intra-Arterial Delivery of drugs into an artery. Injections, Intraarterial,Intra-Arterial Injections,Intraarterial Injections,Injection, Intra-Arterial,Injection, Intraarterial,Injections, Intra Arterial,Intra Arterial Injections,Intra-Arterial Injection,Intraarterial Injection
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007958 Leukocyte Count The number of WHITE BLOOD CELLS per unit volume in venous BLOOD. A differential leukocyte count measures the relative numbers of the different types of white cells. Blood Cell Count, White,Differential Leukocyte Count,Leukocyte Count, Differential,Leukocyte Number,White Blood Cell Count,Count, Differential Leukocyte,Count, Leukocyte,Counts, Differential Leukocyte,Counts, Leukocyte,Differential Leukocyte Counts,Leukocyte Counts,Leukocyte Counts, Differential,Leukocyte Numbers,Number, Leukocyte,Numbers, Leukocyte
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D011479 Protamines A group of simple proteins that yield basic amino acids on hydrolysis and that occur combined with nucleic acid in the sperm of fish. Protamines contain very few kinds of amino acids. Protamine sulfate combines with heparin to form a stable inactive complex; it is used to neutralize the anticoagulant action of heparin in the treatment of heparin overdose. (From Merck Index, 11th ed; Martindale, The Extra Pharmacopoeia, 30th ed, p692) Protamine,Protamine Sulfate,Protamine Chloride,Chloride, Protamine,Sulfate, Protamine
D011652 Pulmonary Circulation The circulation of the BLOOD through the LUNGS. Pulmonary Blood Flow,Respiratory Circulation,Circulation, Pulmonary,Circulation, Respiratory,Blood Flow, Pulmonary,Flow, Pulmonary Blood,Pulmonary Blood Flows
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D003167 Complement Activation The sequential activation of serum COMPLEMENT PROTEINS to create the COMPLEMENT MEMBRANE ATTACK COMPLEX. Factors initiating complement activation include ANTIGEN-ANTIBODY COMPLEXES, microbial ANTIGENS, or cell surface POLYSACCHARIDES. Activation, Complement,Activations, Complement,Complement Activations

Related Publications

M Tulunay, and S Demiralp, and S Tastan, and H Akalin, and U Ozyurda, and T Corapcioglu, and E S Akarsu
March 1984, The Annals of thoracic surgery,
M Tulunay, and S Demiralp, and S Tastan, and H Akalin, and U Ozyurda, and T Corapcioglu, and E S Akarsu
April 1988, Zhonghua xin xue guan bing za zhi,
M Tulunay, and S Demiralp, and S Tastan, and H Akalin, and U Ozyurda, and T Corapcioglu, and E S Akarsu
April 1984, British journal of anaesthesia,
M Tulunay, and S Demiralp, and S Tastan, and H Akalin, and U Ozyurda, and T Corapcioglu, and E S Akarsu
February 1986, The Annals of thoracic surgery,
M Tulunay, and S Demiralp, and S Tastan, and H Akalin, and U Ozyurda, and T Corapcioglu, and E S Akarsu
December 1994, The Journal of thoracic and cardiovascular surgery,
M Tulunay, and S Demiralp, and S Tastan, and H Akalin, and U Ozyurda, and T Corapcioglu, and E S Akarsu
May 1985, British heart journal,
M Tulunay, and S Demiralp, and S Tastan, and H Akalin, and U Ozyurda, and T Corapcioglu, and E S Akarsu
March 1995, Clinical chemistry,
M Tulunay, and S Demiralp, and S Tastan, and H Akalin, and U Ozyurda, and T Corapcioglu, and E S Akarsu
January 2006, The American journal of cardiology,
M Tulunay, and S Demiralp, and S Tastan, and H Akalin, and U Ozyurda, and T Corapcioglu, and E S Akarsu
April 2009, Atherosclerosis,
M Tulunay, and S Demiralp, and S Tastan, and H Akalin, and U Ozyurda, and T Corapcioglu, and E S Akarsu
September 1985, Surgery,
Copied contents to your clipboard!